| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/18/2001 | EP1115852A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 07/18/2001 | EP1115851A1 Method of screening for large offspring syndrome |
| 07/18/2001 | EP1115849A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway |
| 07/18/2001 | EP1115844A2 Sequenzes of putative plant acyltransferases |
| 07/18/2001 | EP1115841A1 Stable neural stem cell lines |
| 07/18/2001 | EP1115840A2 Lineage specific cells and progenitor cells |
| 07/18/2001 | EP1115746A2 Antibodies to mammalian langerhans cell antigen and their uses |
| 07/18/2001 | EP1115740A1 Synthetic peptides, conjugation reagents and methods |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115734A1 Method of measuring protein-protein interactions in living cells |
| 07/18/2001 | EP1115433A1 Functionalized derivatives of hyaluronic acid, formation of hydrogels and in situ using same |
| 07/18/2001 | EP1115432A1 Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge |
| 07/18/2001 | EP1115277A1 Novel method of regulating seed development in plants and genetic sequences therefor |
| 07/18/2001 | EP0752869B1 Cells with multiple altered epitopes on a surface antigen for use in transplantation |
| 07/18/2001 | EP0575555B1 Protein-induced morphogenesis |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304450A Novel insulin analogs with enhanced zinc binding |
| 07/18/2001 | CN1304449A Novel angiotensin receptor, production and use thereof |
| 07/18/2001 | CN1304446A Poly (ADP-ribose) polymerse gene |
| 07/18/2001 | CN1304445A Method for producing cloned tigers by employing inter-species nuclear transplantation technique |
| 07/18/2001 | CN1304444A Method for producing human cloned embryos by employing inter-species nuclear transplantation technique |
| 07/18/2001 | CN1304443A Method for producing clened cows |
| 07/18/2001 | CN1304317A Nucleic acid encoding hyaluronan synthase and method of use |
| 07/18/2001 | CN1303924A Method for culturing anchorage dependent animal cell to produce virus by using magnetic stable fluidized bed |
| 07/18/2001 | CA2296997A1 Treatment of congestive heart failure |
| 07/17/2001 | USRE37287 Chimeric gene for the transformation of plants |
| 07/17/2001 | US6262339 Transforming plant cells with dna sequences that inhibit expression of essential metabolic compounds and regenerating plants from said cells; reversible by supplying given amino acids |
| 07/17/2001 | US6262248 Dna encoding an arabidopsis thaliana rps2 polypeptide in plant cells provides resistance to pathogens |
| 07/17/2001 | US6262247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/17/2001 | US6262246 DNA encoding mammalian neuropeptides FF (NPFF) receptors and uses thereof |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262242 Tumor suppressor designated TS10Q23.3 |
| 07/17/2001 | US6262237 Contacting protocadherin-encoding polynucleotide sequence with antibody (monoclonal, polyclonal, chimeric or humanized) antagonizes homophilic binding; useful for intercellular adhesion |
| 07/17/2001 | US6262233 Tissue factor pathway inhibitor-3 |
| 07/17/2001 | US6262232 Recombinant C-terminal α-amidating enzyme |
| 07/17/2001 | US6262026 Chimeric proteins for use in transport of a selected substance into cells |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6262018 Hypersensitive response elicitor from Erwinia amylovora and its use |
| 07/17/2001 | US6262017 Peptides for altering osteoblast adhesion |
| 07/17/2001 | US6261841 Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells |
| 07/17/2001 | US6261840 Nucleotide sequences for gene expression inhibition of protein phosphatase 1b, a protein tyrosine phosphatase; diagnosis and antisense therapy of related diseases |
| 07/17/2001 | US6261839 Method for the induction of a NK cell-mediated immune response |
| 07/17/2001 | US6261832 Automated cell processor |
| 07/17/2001 | US6261820 Fibronolytically active polypeptide |
| 07/17/2001 | US6261819 Compounds |
| 07/17/2001 | US6261818 Nucleotide sequence of cardiac-related ankyrin-repeat protein kinase; antisense agents; probes; primers; vectors; host cells; antibodies; diagnosis and treatment of cardiovascular disorders |
| 07/17/2001 | US6261817 Guaa |
| 07/17/2001 | US6261805 Sialyiation of N-linked glycoproteins in the baculovirus expression vector system |
| 07/17/2001 | US6261802 Ups (ugc) |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261791 Method for diagnosing cancer using specific PSCA antibodies |
| 07/17/2001 | US6261790 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 07/17/2001 | US6261587 Contacting with matrix containing gelatin and nitric acid inhibitor |
| 07/17/2001 | US6261585 Increasing blood flow to ischemic aanimal tissue |
| 07/17/2001 | US6261561 Administering intimin or fusion protein |
| 07/17/2001 | US6261559 Inhalation device |
| 07/17/2001 | US6261558 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 07/17/2001 | US6261554 Compositions for targeted gene delivery |
| 07/17/2001 | US6261551 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 07/17/2001 | US6261549 Human mesenchymal stem cells from peripheral blood |
| 07/17/2001 | US6261548 Polypeptides for leukemia inhibitor factors with amino acid sequences |
| 07/17/2001 | CA2151141C Mammalian receptors for interleukin-10 (il-10) |
| 07/17/2001 | CA2055615C Monoclonal antibodies for inducing tolerance |
| 07/12/2001 | WO2001049870A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049859A1 Trichoderma reesei xylanase |
| 07/12/2001 | WO2001049851A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | WO2001049838A2 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 07/12/2001 | WO2001049833A2 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 07/12/2001 | WO2001049832A2 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | WO2001049829A1 Compositions and methods for efficient aav vector production |
| 07/12/2001 | WO2001049828A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/12/2001 | WO2001049827A1 Methods and compositions for reconstruction of multilayered tissue structures |
| 07/12/2001 | WO2001049825A1 Methods for protein transfer |
| 07/12/2001 | WO2001049824A2 Cell growth substrate hydrogels |
| 07/12/2001 | WO2001049821A2 Th1 specific cd4 t cell lines and method for inducing them ex vivo |
| 07/12/2001 | WO2001049745A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 07/12/2001 | WO2001049742A1 Method for making insulin precursors and insulin precursor analogs |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049717A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049243A2 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 07/12/2001 | WO2001049210A1 Methods and compositions for organ decellularization |
| 07/12/2001 | WO2001049113A1 Spore-like cells and uses thereof |
| 07/12/2001 | WO2001049106A2 Method for cloning animals with targetted genetic alterations |
| 07/12/2001 | WO2001023528A8 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| 07/12/2001 | WO2001012665A3 Helical cytokine zalpha48 |
| 07/12/2001 | WO2001004281A3 Dna coding for beta-tubulin and use thereof |
| 07/12/2001 | WO2001002588A3 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 07/12/2001 | WO2000078928A3 Surface for cell culture |
| 07/12/2001 | WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 07/12/2001 | WO2000065070A3 Cell culture process for glycoproteins |
| 07/12/2001 | WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000032750A9 Transgenic circulating endothelial cells |
| 07/12/2001 | WO2000017321A9 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering |
| 07/12/2001 | WO2000004041A3 Methods and molecules relating to cd39-like polypeptides |
| 07/12/2001 | WO2000000510A3 Growth factor modulators |
| 07/12/2001 | WO1999064559A3 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device |